Oleanolic acid inhibits hypertrophic scarring in the rabbit ear model

Area of Science:

• Dermatology
• Wound Healing
• Pharmacology

Background:

• Hypertrophic scarring is a proliferative disorder of dermal fibroblasts characterized by excessive collagen and extracellular matrix deposition.
• Current treatments like surgical excision or steroid hormones have limitations and potential complications.
• Investigating novel therapeutic agents is crucial for managing hypertrophic scarring.

Purpose of the Study:

• To evaluate the efficacy of oleanolic acid (OA), a natural triterpenoid, in mitigating hypertrophic scarring.
• To assess the impact of OA on key molecular markers and tissue characteristics of scars.
• To determine the potential of OA as a treatment for hypertrophic scarring.

Main Methods:

• A rabbit ear model was utilized to induce hypertrophic scars using a biopsy punch.
• Oleanolic acid (2.5%, 5%, 10%) was topically applied daily for 22 days.
• Scar tissue was analyzed for collagen I/III, MMP-1, TGF-β(1) levels, scar elevation index (SEI), and histological changes.

Main Results:

• Oleanolic acid significantly inhibited hypertrophic scarring in the rabbit ear model.
• OA treatment led to decreased levels of transforming growth factor-beta 1 (TGF-β(1)), collagen I, and collagen III.
• A significant increase in matrix metalloproteinase-1 (MMP-1) and a reduction in the scar elevation index (SEI) were observed.
• Histological examination confirmed significant amelioration of scar tissue.

Conclusions:

• Oleanolic acid demonstrates significant suppression of hypertrophic scarring in a preclinical rabbit model.
• OA modulates key molecular pathways involved in scar formation, including collagen synthesis and extracellular matrix remodeling.
• These findings suggest that oleanolic acid may represent a promising therapeutic option for human hypertrophic scarring.